MB

Mariya Bekirska

Associate Director, Project Management (real World Evidence Solutions) at Evidera

Mariya Bekirska is a seasoned professional with extensive experience in project and operations management in the healthcare consulting sector. Currently serving as a Senior Project Manager for Evidera, Mariya oversees the coordination and management of real-world evidence consulting projects, ensuring successful completion from inception to close-out. Prior experience at C3i Solutions included roles such as Senior Program Manager, where Mariya established client relationships and ensured delivery of services, as well as Senior Operations Manager and other positions focused on staffing and operational effectiveness across multiple countries. Mariya holds a Master's degree in Regulations and Standards in Medicine from New Bulgarian University and a Bachelor's degree in Philosophy from Sofia University St. Kliment Ohridski.

Location

Sofia, Bulgaria

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Evidera

1 followers

Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.